Cardiovascular Risk Assessment in Patients Treated With Caduet
Clinical trial NCT00297973 · COMPLETED
Trial details
- NCT number
- NCT00297973
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Enrollment
- 1442
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.